Medical News

RSS

Enavail to build new cGMP facility in Abilene Life Sciences Accelerator

Enavail, LLC, a particle engineering company founded on pioneering drug delivery research from the University of Texas at Austin, announced today the company's plans for the construction of a new state-of-the-art current Good Manufacturing Practices (cGMP) facility in the Abilene Life Sciences Accelerator (ALSA). The Enavail facility will be the first of its kind in the West Texas region.

9 Jun 2010

Discovery Labs reports preliminary results from Surfaxin Phase 2 trial in children with Acute Respiratory Failure

Discovery Laboratories, Inc., reports preliminary results from its Phase 2 clinical trial of Surfaxin® in children with Acute Respiratory Failure (ARF), a critical condition often caused in children by severe respiratory infections. The objective of the study was to evaluate the safety and tolerability of intratracheal administration of Surfaxin and to assess whether Surfaxin treatment could decrease the duration of mechanical ventilation in children with ARF.

9 Jun 2010

Accuray forms strategic alliance with Siemens

Accuray, a global leader in the field of radiosurgery, today announced that it has formed a strategic alliance with Siemens. The strategic alliance is expected to extend the global sales reach for Accuray's CyberKnife Robotic Radiosurgery System while creating a research-and-development alliance aimed at developing and commercializing innovative new technologies and products.

9 Jun 2010

Cardinal Health to purchase Healthcare Solutions Holding for $517M

Cardinal Health today announced plans to expand its presence in specialty pharmaceutical services with a definitive agreement to purchase Healthcare Solutions Holding, LLC in an upfront $517 million all-cash transaction. The agreement also includes the opportunity for earn-out payments of up to $150 million over the next three years.

9 Jun 2010

Correlogic Systems' OvaCheck blood test for detection of epithelial ovarian cancer receives CE Mark

Correlogic Systems, Inc. announced today that OvaCheck, the company's blood test for the detection of epithelial ovarian cancer, has fulfilled European Union regulatory requirements (CE marking) for distribution and sale of the test. The path is now cleared for the test to be made available to patients in Europe through their physicians.

9 Jun 2010

PulmoBind product candidate has potential for early diagnosis of PH in pediatric population

Pulmo BioTech Inc. has announced that early indications are that its PulmoBind product candidate has the potential for early diagnosis of Pulmonary Hypertension in the pediatric population. PH is a potentially life threatening and crippling disease; it is also very hard to diagnose.

9 Jun 2010

CGH, FISH techniques effective for postmortem analysis of fetuses, infants with congenital anomalies

New techniques to detect chromosomal abnormalities can offer a higher degree of accuracy. Chromosomal abnormalities are a well-known cause of multiple congenital anomalies, and conventional methods of culture analysis have proven unsuccessful in 10% to 40% of cases. Comparative genomic hybridization (CGH) and fluorescent in situ hybridization (FISH) techniques were tested and found successful by analyzing tissue from children who had multiple congenital anomalies.

9 Jun 2010

New AAN guideline provides step-by-step process for determining brain death in adults

In an effort to create a uniform and accurate method for determining brain death, the American Academy of Neurology has issued an updated guideline that provides doctors with a step-by-step process for determining brain death in adults. The guideline is published in the June 8, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.

9 Jun 2010

CXCR4 protein restores brain damage in multiple sclerosis patients

A protein that helps build the brain in infants and children may aid efforts to restore damage from multiple sclerosis (MS) and other neurodegenerative diseases, researchers at Washington University School of Medicine in St. Louis have found.

9 Jun 2010

RCSI scientists make breakthrough in understanding human adaptation to high altitude environments

A group of top international scientists including geneticists from the Royal College of Surgeons in Ireland has made a breakthrough in understanding human adaptation to high altitude environments.

9 Jun 2010

DuPont reaches regulatory milestone with confirmation of Plenish high oleic soybean trait

DuPont announced it has reached a regulatory milestone and the final step of the U.S. regulatory process with confirmation from the United States Department of Agriculture that its Plenish high oleic soybean trait has been approved for cultivation in the United States.

9 Jun 2010

Personality traits influence reproductive success

The reproductive success of both men and women is influenced by our personality traits, according to new research from the University of Sheffield.

9 Jun 2010

New report compares U.S. and European funding for research related to synthetic biology

A new analysis by the Synthetic Biology Project at the Woodrow Wilson Center found that the U.S. government has spent around $430 million on research related to synthetic biology since 2005, with the Department of Energy funding a majority of the research. By comparison, the analysis indicated that the European Union and three individual European countries – the Netherlands, United Kingdom, and Germany – had spent approximately $160 million during that same period.

9 Jun 2010

Simcyp releases Population-based ADME Simulator Version 10.0

Simcyp Limited today announces that it has released the latest version of its flagship simulator, further cementing its position as the industry leader in modelling and simulation of drug-drug interactions (DDIs) in virtual populations.

9 Jun 2010

Forterus signs agreements with J.P. Morgan Chase and other independent investors

Forterus, Inc. today announced that it has signed agreements with J.P. Morgan Chase & Co. and other independent investors to provide financing to qualified consumers seeking behavioral healthcare services.

9 Jun 2010

Resverlogix' RVX-208 increases plasma levels of Apolipoprotein A-I and HDL-cholesterol

Resverlogix is pleased to announce that it has collaborated with the Division of Cardiology at the Research Institute of the McGill University Health Centre (RI of the MUHC), to publish today in the Journal of American College of Cardiology (JACC), a report entitled 'RVX-208 A Small Molecule that Increases Apolipoprotein A-I and High Density Lipoprotein Cholesterol In Vitro and In Vivo'.

9 Jun 2010

NWBT announces release of new detailed report by Pharmaceuticals and Biotech Analyst

Northwest Biotherapeutics, Inc., developer of the DCVax personalized cancer vaccine, today announced the release of a new detailed report by Pharmaceuticals and Biotech Analyst Dr. Navid Malik of the London-based Matrix Group.

9 Jun 2010

Connections project to debate effectiveness of drug and alcohol interventions within criminal justice system

The second annual European gathering of the Connections project, a University of Kent-managed project co-funded by the European Commission Public Health Programme, will debate the ethics, effectiveness and economics of drug and alcohol interventions within the criminal justice system.

9 Jun 2010

Update on Phase II clinical study of CH-4051 in rheumatoid arthritis

Chelsea Therapeutics International, Ltd. announced that during a teleconference yesterday, the U.S. Food and Drug Administration requested that the company delay the initiation of its proposed Phase II clinical study of CH-4051 in rheumatoid arthritis and indicated that the agency is requesting additional detail from the preclinical studies previously submitted as part of the company's investigational new drug application.

9 Jun 2010

Faith-based HIV-prevention program for African-American women and girls

Developing and evaluating a faith-based, HIV-prevention program for African-American mothers and their daughters is the focus of Dr. Chisina Kapungu's $795,000 career development grant from the National Institute of Mental Health.

9 Jun 2010

Medical News

Enavail to build new cGMP facility in Abilene Life Sciences Accelerator

Discovery Labs reports preliminary results from Surfaxin Phase 2 trial in children with Acute Respiratory Failure

Accuray forms strategic alliance with Siemens

Cardinal Health to purchase Healthcare Solutions Holding for $517M

Correlogic Systems' OvaCheck blood test for detection of epithelial ovarian cancer receives CE Mark

PulmoBind product candidate has potential for early diagnosis of PH in pediatric population

CGH, FISH techniques effective for postmortem analysis of fetuses, infants with congenital anomalies

New AAN guideline provides step-by-step process for determining brain death in adults

CXCR4 protein restores brain damage in multiple sclerosis patients

RCSI scientists make breakthrough in understanding human adaptation to high altitude environments

DuPont reaches regulatory milestone with confirmation of Plenish high oleic soybean trait

Personality traits influence reproductive success

New report compares U.S. and European funding for research related to synthetic biology

Simcyp releases Population-based ADME Simulator Version 10.0

Forterus signs agreements with J.P. Morgan Chase and other independent investors

Resverlogix' RVX-208 increases plasma levels of Apolipoprotein A-I and HDL-cholesterol

NWBT announces release of new detailed report by Pharmaceuticals and Biotech Analyst

Connections project to debate effectiveness of drug and alcohol interventions within criminal justice system

Update on Phase II clinical study of CH-4051 in rheumatoid arthritis

Faith-based HIV-prevention program for African-American women and girls

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News